Results 131 to 140 of about 312,196 (386)

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Drug Points: Apparent interaction between warfarin and levonorgestrel used for emergency contraception [PDF]

, 2000
No abstract ...
Ellison, J., Greer, I.A., Thomson, A.J., Walker, I.D.   +3 more
core   +2 more sources

Cardiovascular Risk Factors Associated With Venous Thromboembolism

JAMA cardiology, 2019
Importance It is uncertain to what extent established cardiovascular risk factors are associated with venous thromboembolism (VTE). Objective To estimate the associations of major cardiovascular risk factors with VTE, ie, deep vein thrombosis and ...
J. Gregson, S. Kaptoge, T. Bolton, L. Pennells, P. Willeit, S. Burgess, S. Bell, M. Sweeting, E. Rimm, C. Kabrhel, Bengt Zöller, G. Assmann, V. Gudnason, A. Folsom, V. Arndt, A. Fletcher, P. Norman, B. Nordestgaard, A. Kitamura, B. Mahmoodi, P. Whincup, M. Knuiman, V. Salomaa, C. Meisinger, W. Koenig, M. Kavousi, H. Völzke, J. Cooper, T. Ninomiya, E. Casiglia, B. Rodríguez, Y. Ben-Shlomo, J. Despres, L. Simons, E. Barrett-Connor, C. Björkelund, M. Notdurfter, D. Kromhout, J. Price, S. Sutherland, J. Sundström, J. Kauhanen, J. Gallacher, J. Beulens, R. Dankner, C. Cooper, S. Giampaoli, J. Deen, A. Gómez de la Cámara, L. Kuller, A. Rosengren, P. Svensson, D. Nagel, C. Crespo, H. Brenner, J. Albertorio-Díaz, R. Atkins, E. Brunner, M. Shipley, I. Njølstad, D. Lawlor, Y. T. van der Schouw, R. Selmer, M. Trevisan, W. Verschuren, P. Greenland, S. Wassertheil-Smoller, G. Lowe, A. Wood, A. Butterworth, S. Thompson, J. Danesh, E. di Angelantonio, T. Meade   +73 more
semanticscholar   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Comorbid Conditions in Idiopathic Pulmonary Fibrosis: Recognition and Management. [PDF]

, 2017
Idiopathic pulmonary fibrosis (IPF), a fibrosing interstitial pneumonia of unknown etiology, primarily affects older adults and leads to a progressive decline in lung function and quality of life.
Collard, Harold R, Oldham, Justin M
core   +2 more sources

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Non-valvular atrial fibrillation and stroke : implications for management [PDF]

, 1995
Nonvalvular Atrial Fibrillation is more prevalent with increasing age. It is associated with a six-fold excess risk of stroke; and a cumulative lifetime stroke risk of 35%. 15% of ischaemic strokes are directly attributable to it.
Tilney, Myra Kay
core  

Varicose Veins, Oral Contraceptives, and Thromboembolism [PDF]

, 1967
George R. Fegan
openalex   +3 more sources

Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis

British medical journal, 2019
Objectives To determine the rate of a first recurrent venous thromboembolism (VTE) event after discontinuation of anticoagulant treatment in patients with a first episode of unprovoked VTE, and the cumulative incidence for recurrent VTE up to 10 years ...
F. Khan, Alvi Rahman, M. Carrier, C. Kearon, J. Weitz, S. Schulman, F. Couturaud, S. Eichinger, P. Kyrle, C. Becattini, G. Agnelli, T. Brighton, A. Lensing, M. Prins, E. Sabri, B. Hutton, L. Pinède, M. Cushman, G. Palareti, G. Wells, P. Prandoni, H. Büller, M. Rodger   +22 more
semanticscholar   +1 more source

Cardiovascular toxicity induced by TKIs in patients with chronic myeloid leukaemia: Are women and men different?

ESC Heart Failure, Volume 12, Issue 2, Page 1447-1454, April 2025.
This study analyzes 148 patients (66 women and 82 men) with chronic myeloid leukemia treated with tyrosine kinase inhibitors, focusing on cardiovascular adverse events. The risk assessment, performed using the HFA/ICOS score, reveals sex‐specific differences: venous thrombosis is more common in women, while arterial thrombosis predominates in men.
Cristina Madaudo, Daniela Di Lisi, Antonio Cannatà, Federica Manfrè, Celeste Vullo, Marco Santoro, Ciro Botta, Salvatrice Mancuso, Sergio Siragusa, Alfredo Ruggero Galassi, Giuseppina Novo   +10 more
wiley   +1 more source